SCICLONE PHARMACEUTICALS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
SCICLONE PHARMACEUTICALS INC reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $18.87 million for the 12-month period ending 2011-12-31, per its 10-K filed 2014-03-17.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2014-03-17
- SCICLONE PHARMACEUTICALS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2011 was $18.87M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|
| 2011-12-31 | $18.87M 10-K · filed 2014-03-17 |